Integrium is a full-service clinical research organization (CRO) focused on the therapeutic areas of cardiovascular disease, metabolic disease, and dermatology. We have the scientific, medical, operational, and regulatory expertise to cover all stages of clinical development from single-site, first-in-man studies to multi-national pivotal trials with hundreds of sites and thousands of patients.
Because we understand the complexities and nuances of clinical research in the cardiovascular disease, metabolic disease, and dermatology areas, Integrium delivers successful, engineered clinical study solutions to biopharmaceutical companies. We can help design scientifically rigorous, yet feasible studies. We know reliable, high-quality, productive investigators and work well with them. We know where and how to get the needed patients for a particular study. We provide study teams with experience levels far above industry norms that know how to work seamlessly and efficiently with our clients, and achieve or beat timelines.
Integriumís client base is diverse, consisting of specialty, small, mid-size, and large companies. We have solid, long-term working relationships characterized by high repeat business rates with many of our clients. Our engagements have ranged from those consisting of highly customized, comprehensive management services for a multi-study program to functional-level support for an individual trial. Integrium has the flexibility and breadth required to serve a wide array of clinical development needs for its biopharmaceutical company clients.
Integrium provides its clients with unparalleled service. Our employees are deeply committed to client satisfaction. We take a highly collaborative, partnering approach when working with our clients. Taking the extra steps that are frequently required to deliver outstanding performance is part of our corporate culture. Our management team is readily accessible to clients. In fact, we assign one or more senior manager to each study team to provide therapeutic and operational support to the client and Integrium members of the team.
Integrium was founded in 1998 by clinical research thought leaders that wanted to build a CRO based on therapeutic focus and excellence. These individuals continue to lead the company today. We have offices in North America and South Africa, and formal alliances with regional, partner CROs in Europe, Australia, and India. Integrium is privately owned.